OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
26
Results
Show all
Save search
Copy query
Show results for
Unknown
(26)
Publication Date
Release Date
2021
(7)
2022
(5)
2024
(4)
2023
(3)
2016
(3)
2025
(1)
2020
(1)
2017
(1)
2015
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Not available
S-EPMC4985288
|
biostudies-literature
Cite
Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: Results from the IMPACC study.
Not available
S-EPMC9359694
|
biostudies-literature
Cite
Features of acute COVID-19 associated with post-acute sequelae of SARS-CoV-2 phenotypes: results from the IMPACC study.
Not available
S-EPMC10764789
|
biostudies-literature
Cite
Targeted Temperature Management After Pediatric Cardiac Arrest Due To Drowning: Outcomes and Complications.
Not available
S-EPMC5123789
|
biostudies-literature
Cite
Therapeutic Hypothermia after In-Hospital Cardiac Arrest in Children.
Not available
S-EPMC5310766
|
biostudies-literature
Cite
Therapeutic hypothermia after out-of-hospital cardiac arrest in children.
Not available
S-EPMC4470472
|
biostudies-literature
Cite
Pediatric Out-of-Hospital Cardiac Arrest Characteristics and Their Association With Survival and Neurobehavioral Outcome.
Not available
S-EPMC5138073
|
biostudies-literature
Cite
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.
Not available
S-EPMC7787219
|
biostudies-literature
Cite
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8084355
|
biostudies-literature
Cite
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC10957483
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets